-
Embryo-fetal erythroid cell selection from celomic fluid allows earlier prenatal diagnosis of hemoglobinopathies.
Giambona A, Damiani G, Leto F, Jakil C, Renda D, Cigna V, Schillaci G, Picciotto F, Nicolaides KH, Passarello C, Makrydimas G, Maggio A.
Prenat Diagn 2016;36:375-81. pdf -
Assessment of the corpus callosum at 20-24 weeks' gestation by three-dimensional ultrasound examination.
Plasencia W, Dagklis T, Borenstein M, Csapo B, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:169-72. -
Cell-free DNA levels in pregnancies at risk of sickle-cell disease and significant ethnic variation.
Gerovassili A, Nicolaides KH, Thein SL, Rees DC.
Br J Haematol 2006;135:738-41. -
Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K, Crossley JA, Aitken DA, Nicolaides KH.
Prenat Diagn 2005;25:358-61. -
Mass spectral analysis of asymmetric hemoglobin hybrids: demonstration of Hb FS alpha2gammabetaS) in sickle cell disease.
Ofori-Acquah SF, Green BN, Davies SC, Nicolaides KH, Serjeant GR, Layton DM.
Anal Biochem 2001;298:76-82. -
Cerebellar hypoplasia, facial dysmorphism and internal abnormalities: a new recessive syndrome?
Seller MJ, Pal K, Moscoso G, Nicolaides K, Hyett JA.
Clin Dysmorphol 1998;7:41-4. -
Audit of prenatal diagnosis for hemoglobin disorders in the United Kingdom The first twenty years.
Modell B, Petrou M, Layton M, Varnavides L, Moisely C, Ward RH, Rodeck C, Nicolaides K, Fitches A, Old J.
Ann N Y Acad Sci 1998;850:420-2. -
Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: The first 20 years.
Modell B, Petrou M, Layton M, Varnavides L, Slater C, Ward R H, Rodeck C, Nicolaides KH, Gibbons S, Fitches A, Old J.
BMJ 1997;315:779-84.